Mosquito-Associated Virus Isolation from Field-Collected Mosquitoes
August 31st, 2022
Numerous novel virus-like sequences have been found in mosquitoes due to the extensive use of sequencing technologies. We provide an effective procedure for isolating and amplifying viruses using vertebrate and mosquito cell lines, which might serve as the basis for future studies on mosquito-associated viruses, including mosquito-borne and mosquito-specific viruses.
This protocol is a useful approach for isolating mosquito-associated viruses and can help in further research into the distribution of pathogens related to mosquitoes and the control of mosquito-borne diseases. Using thin lines to isolate viruses in Biosafety level 2 laboratory is safer and more efficient. Unlike other virus isolation procedures, such as cycling red inoculation with varying fluid, this technique does not necessitate animal experimentation or ethical assessment.
The contamination from samples and the cells drawing during the incubation can lead to the failure of the experiment. Hence, it is necessary to add 2%Penicillin-Streptomycin-Amphotericin into the medium to prevent contamination. Begin with the addition of three-millimeter ceramic beads, 1.5 milliliters of RPMI medium supplemented with 2%Penicillin-Streptomycin-Amphotericin B Solution in a two-milliliter sterile tube placed on ice and then transfer 50 mosquitoes in it.
Next, homogenize the mosquitoes with a low temperature tissue homogenizer by grinding for 30 seconds at 70 hertz and 4 degrees Celsius for 3 cycles. Centrifuge the homogenate at 15, 000 G for 30 minutes at 4 degrees Celsius and transfer the supernatants to the new tubes. To remove the mosquito debris completely, centrifuge the supernatant again at 15, 000 G for 10 minutes at 4 degrees Celsius.
Aliquot the 200 microliters of supernatant P0 into a two-milliliter screw cap storage tube, and store it at minus 80 degrees Celsius. For the virus amplification, use Aedes albopictus RNAi-deficient mosquito cell line C6/36 and a vertebrate cell line, baby hamster kidney, or BHK-21 from a 75-centimeter square flask and seed them in 24 well plates separately. Place the seeded 24 well plate overnight at 28 or 37 degrees Celsius.
The next day, observe the cells under the microscope to confirm 80 to 90%confluency in each well. Prepare 500 milliliters of the cell culture maintenance medium supplemented with antibiotics. Remove the cell culture medium from the 24 well plates and add 100 microliters of the cell culture maintenance medium to each well.
Then inoculate the cells with 100 microliters of the supernatant of the mosquito homogenate or P0.Incubate the plates at 28 or 37 degrees Celsius for 60 minutes and gently shake the plates after every 15 minutes to prevent the drying of the cells. Once done, remove the supernatant and rinse each well with 600 microliters of cell culture maintenance medium to remove the debris completely. Next, add 800 microliters of cell culture maintenance medium to each well before placing the plates in a 5%carbon dioxide humidified incubator at 28 or 37 degrees Celsius for 7 days.
Daily monitor the state of the cells of each well under the microscope. On the seventh day, collect the supernatant of cells known as P1 and store it at minus 80 degrees Celsius. Repeat the procedure to collect P2 and P3 viral supernatants.
Due to the cytopathogenic effect, or CPE, cells from some of the wells die and detach from the surface. To greatly amplify the viruses Collect 300 to 400 microliters of the supernatant from wells showing the CPE effect and transfer it to a new six-well plate having 80 to 90%cell confluency of culture cells. Finally, collect and transfer 500 microliters of the supernatant from the wells of the six-well plate to two-milliliter screw cap storage tubes before storing them at minus 80 degrees Celsius.
The inoculation of C6/36 cells with the mosquito homogenates P0 exhibited a wide intercellular space in exfoliated cells at 120 hours post-infection period compared to the uninoculated or control cells. Incubation of BHK21 cells with the P3 viral supernatants demonstrated a visible CPE at 48 hours post-infection, displaying the death of the cell and detachment from the surface in contrast to the control cells. Commercially available universal primers or Flaviviruses, Alphaviruses and Bunyaviruses were used to generate the PCR products for the viral supernatant.
A PCR product for the Bunyavirus, Ebinur Lake virus, was set as a positive control. The PCR amplification bans in lanes belonging to Bunyaviruses and the positive control highlighted the possibility of the presence of Bunyavirus in the supernatants. To improve the success rate of virus isolation, keep a low temperature during sample transportation, isolation, and grinding.
Add antibiotics when homogenizing the mosquitoes and the culture itself. And handle the culture rapidly during incubation and the removing the culture medium. In addition to this procedure, the grinding solution can be injected into a cycling rat or chicken embryo.
However, the affirmation procedure will raise ethical concerns and increase the expense of the experiment.
View the full transcript and gain access to thousands of scientific videos
Overview
This study presents an effective protocol for isolating and amplifying mosquito-associated viruses using both Aedes albopictus mosquito cell lines and vertebrate cell lines. The method is designed to enhance research into mosquito-borne diseases while ensuring safety and ethical compliance.
Key Study Components
Research Area
- Virus isolation techniques
- Mosquito-borne pathogens
- Cell culture methodologies
Background
- Increasing discovery of novel virus-like sequences in mosquitoes
- Need for ethical and efficient isolation methods
- Importance of understanding mosquito-associated viruses
Methods Used
- Homogenization and centrifugation of mosquito samples
- Use of Aedes albopictus and BHK-21 cell lines
- Application of PCR for viral detection and amplification
Main Results
- Successful amplification of viruses from mosquito homogenates
- Development of a safer protocol that minimizes contamination risks
- Detection of specific viruses using PCR techniques
Conclusions
- The study establishes a reliable method for isolating viruses from mosquitoes.
- It contributes valuable insights for future research on mosquito-borne viral diseases.
Frequently Asked Questions
Executive Industry Relevance
Reliable isolation and amplification of mosquito-associated viruses from field samples is critical for early-stage pathogen discovery and risk assessment in vector-borne disease research. This protocol enables standardized, animal-free workflows for generating virus stocks and characterizing novel viral agents, supporting predictive confidence in vector-pathogen surveillance. The approach underpins translational continuity from field collection to laboratory analysis, informing portfolio decisions in infectious disease R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of viral presence and replication in both mosquito and vertebrate cell systems.
- Supports biological de-risking by distinguishing between mosquito-specific and potentially zoonotic viruses.
- Facilitates functional validation of viral infectivity and cytopathogenicity in controlled settings.
Screening & Assay Development
- Provides validated viral stocks for downstream assay development and screening workflows.
- Standardizes sample preparation and amplification steps to ensure reproducibility and comparability across studies.
- Generates quantitative outputs such as cytopathogenic effect (CPE) and PCR-based viral detection for robust assay readouts.
Translational & Preclinical Research
- Aligns laboratory findings with field-derived viral diversity, supporting translational biomarker discovery.
- Enables risk-adjusted advancement of candidate viruses for further characterization or intervention studies.
- Supports continuity from environmental sampling to preclinical model development when relevant.
Pipeline & Workflow Integration
This protocol bridges field collection and laboratory analysis, positioning virus isolation as a foundational step from early discovery through assay development and translational research.
- Discovery Biology: Supports hypothesis testing on viral prevalence and host specificity in mosquito populations.
- Screening: Delivers reproducible viral stocks and quantitative CPE/PCR outputs for assay readiness.
- Analytics: Enables comparative analysis of viral infectivity and detection across cell lines and passages.
- Translational Research: Facilitates alignment of laboratory findings with field epidemiology for biomarker exploration.
- Enterprise Reuse: Establishes a reusable, standardized workflow for ongoing vector-borne virus surveillance and research.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in vector-pathogen interactions and target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of virus isolation workflows.
- Strategic Value: Informs go/no-go decisions for further characterization or intervention development.
- Portfolio Impact: Supports risk-adjusted prioritization of viral targets for downstream R&D investment.
Implementation Considerations
- Requires expertise in cell culture, virology, and molecular detection techniques.
- Needs access to BSL-2 laboratory infrastructure and validated cell lines (C6/36, BHK-21).
- Demands rigorous contamination control and standardized handling protocols.
- Adaptable to different mosquito species and field conditions with protocol modifications.
- Limitations include potential sample degradation and the need for rapid processing to maximize isolation success.
